Powered by the Consumer Technology Association (CTA)®

Skip to content
2024 Honoree Award

Next-Gen Digital Health: AI-Powered Digital Biomarker

EXOSYSTEMS Inc.
  • 2024 Honoree in Digital Health
Imagine diagnosing neuromuscular disorders in under 2 minutes with a small, pebble-sized wearable.
Introducing our latest product, AI-Powered Digital Biomarker: MFI revolutionizes the diagnosis of neuromuscular and central nervous system diseases by directly analyzing neuromuscular bio-signals at their origin, the motor nerve.

This cutting-edge AI-powered digital health technology addresses critical drawbacks  in conventional assessments by:
 1) eliminating dependency on patient condition,
 2) lowering labor intensity and cost,
 3) enabling remote monitoring.

As easy as using a thermometer, this product elevates neuromuscular disorder diagnosis to a higher standard, offering safety, efficiency, standardization, and patient-friendliness that benefits both patients and healthcare professionals.

Learn More About Digital Health at CES

Explore the latest advancements in AI, IoT, telehealth, and digital health solutions. These groundbreaking technologies are reshaping healthcare delivery, improving patient outcomes, and enhancing operational efficiency.

See More Innovation Awards